Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A founder variant in the RYR1 gene is associated with hyperCKemia, myalgia and muscle cramps

  • Segarra Casas, Alba|||0000-0001-5185-5031
  • Iruzubieta, Pablo
  • Kapetanovic, Solange
  • Hernández-Laín, Aurelio
  • Jericó-Pascual, Ivonne|||0000-0003-4262-6370
  • Fernández-Torrón, Roberto
  • Maneiro, Miren
  • Marco-Moreno, Pablo|||0000-0002-0302-9031
  • Zelaya-Huerta, M. Victoria
  • Rodriguez Santiago, Benjamin|||0000-0003-1167-3852
  • Calafell, Francesc|||0000-0002-1083-9438
  • Töpf, Ana
  • Straub, Volker|||0000-0001-9046-3540
  • Vallejo-Illarramendi, Ainara
  • Lopez de Munain, Adolfo|||0000-0002-9509-4032
  • Gallano, Pia|||0000-0001-8104-2197
  • González Quereda, Lidia|||0000-0003-0715-6414
Background and purpose: Pathogenic variants in the RYR1 gene have been associated with a variety of conditions, ranging from congenital myopathy to adult manifestations. Our aim was to characterize the p.Leu2286Val variant in 17 Basque patients, to accurately determine its correlation with clinical features and to explore the possible founder effect of the variant. Methods: Families harbouring the p.Leu2286 RYR1 variant underwent a detailed clinical evaluation, including muscle magnetic resonance imaging, electromyography and muscle biopsy. Haplotypes were analysed in available patients and their relatives. Results: Individuals carrying the p.Leu2286Val shared a common haplotype, suggesting a founder event in the Basque Country population. The most prevalent features were exertional myalgia, high creatine kinase (CK) levels, cramps and muscle hypertrophy. None of the patients carrying only the p.Leu2286Val showed progression to severe muscle weakness and muscle magnetic resonance imaging showed a heterogeneous muscle involvement. Muscle biopsy revealed non-specific findings in two patients and features associated with central core disease in one patient carrying only the p.Leu2286Val and two patients harbouring an additional RYR1 variant. Three individuals carrying an in trans RYR1 variant presented with an earlier onset and more severe phenotype. Conclusion: Here, it is shown that the dominantly inherited p.Leu2286Val RYR1 founder variant is associated with a milder phenotype of exercise intolerance, myalgia and hyperCKemia.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Translating Muscle RNAseq Into the Clinic for the Diagnosis of Muscle Diseases

  • Segarra Casas, Alba|||0000-0001-5185-5031
  • Domínguez-González, Cristina|||0000-0001-5151-988X
  • Natera-de Benito, Daniel|||0000-0001-7764-2085
  • Kapetanovic, Solange
  • Hernández-Laín, Aurelio
  • Estévez-Arias, Berta|||0000-0002-1711-7489
  • Llansó, Laura|||0000-0003-4950-7657
  • Ortez, Carlos
  • Jou, Cristina|||0000-0002-2223-7880
  • Martí-Carrera, Itxaso
  • López-Márquez, Arístides
  • Rodríguez, Maria José
  • González Mera, Laura
  • Nedkova, Velina
  • Fernández-Torrón, Roberto
  • Rodriguez Santiago, Benjamin|||0000-0003-1167-3852
  • Jiménez Mallebrera, Cecilia|||0000-0001-8203-7103
  • Juntas Morales, Raúl|||0000-0003-2205-1741
  • López-de Munain, Adolfo
  • Surralles, Jordi|||0000-0002-4041-7519
  • Nascimento, Andrés
  • Gallardo, Eduard|||0000-0002-3942-3436
  • Olivé i Plana, Montserrat|||0000-0001-5727-0165
  • Gallano, Pia|||0000-0001-8104-2197
  • González Quereda, Lidia|||0000-0003-0715-6414
Objective: Approximately half of patients with hereditary myopathies remain without a definitive genetic diagnosis after DNA next-generation sequencing (NGS). Here, we implemented transcriptome analysis of muscle biopsies as a complementary diagnostic tool for patients with muscle disease but no definitive genetic diagnosis after exome sequencing. Methods: In total, 70 undiagnosed cases with suspected genetic muscular dystrophies or congenital myopathies were included in the study. Muscle RNAseq comprised the analysis of aberrant splicing, aberrant expression, and monoallelic expression. In addition, existing NGS data or variant calling from RNAseq were reanalyzed, and genome sequencing was performed in selected cases. Four aberrant splicing open-source tools were compared and assessed. Results: RNAseq established a diagnosis in 10/70 patients (14.3%) by identifying aberrant transcripts produced by single nucleotide variants (7/10) or copy number variants (3/10). Reanalysis of NGS data allowed the diagnosis in 9/70 individuals (12.9%). Based on this cohort, FRASER was the tool that reported more splicing outlier events per sample while showing the highest accuracy (81.26%). Conclusions: We demonstrate the utility of RNAseq in identifying causative variants in muscle diseases. Evaluation of four aberrant splicing tools allowed efficient identification of most pathogenic splicing events, obtaining a manageable number of candidate events for manual inspection, demonstrating feasibility for translation into a clinical setting. We also show how the integration of omic technologies reduces the turnaround time to identify causative variants.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Clinical and functional characteristics, possible causes, and impact of chronic cough in patients with cerebellar ataxia, neuropathy, and bilateral vestibular areflexia syndrome (CANVAS)

  • Palones, Esther|||0000-0001-5034-3296
  • Curto Sánchez, Elena|||0000-0002-7291-0543
  • Plaza, Vicente|||0000-0003-2567-5496
  • González Quereda, Lidia|||0000-0003-0715-6414
  • Segarra Casas, Alba|||0000-0001-5185-5031
  • Querol, Luis|||0000-0002-4289-8264
  • Bertoletti, Federico|||0000-0002-1484-3952
  • Rodriguez Fernandez, María José
  • Gallano, Pia|||0000-0001-8104-2197
  • Crespo Lessmann, Astrid|||0000-0002-2238-6851
Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS) is an hereditary autosomal recessive disease. Recent studies propose including chronic cough (CC) as a symptom of CANVAS. For 10 patients with CANVAS as genetically confirmed by biallelic expansion of the AAGG repeat motif (AAGGGexp) in intron 2 of replication factor C subunit 1 (RFC1), our aim was, as a multidisciplinary team, to describe clinical and functional characteristics and possible causes of CC following European Respiratory Society (ERS) recommendations, and to evaluate CC impact on quality of life (QoL) using self-administered questionnaires (Cough Severity Diary, Leicester Cough Questionnaire, Discrete Emotions Questionnaire, and EQ-5D-5L). In all 10 patients, the CC was a dry cough that developed several years prior to the neurological symptoms (mean 14.2 years); 7 patients had symptoms compatible with gastroesophageal reflux (GER), 5 with pathological GER diagnosed by 24-h esophageal pH testing, and 6 patients had impaired esophageal motility diagnosed by high-resolution esophageal manometry, most frequently ineffective peristalsis. Although further studies are required for confirmation, we conclude that CC may be a characteristic prodrome of CANVAS and may be related to GER and esophageal disorders. Furthermore, CC affects patients' QoL, especially in the psychosocial sphere.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genetic diagnosis of Duchenne and Becker muscular dystrophy through mRNA analysis, New splicing events

  • Segarra Casas, Alba|||0000-0001-5185-5031
  • Domínguez-González, Cristina|||0000-0001-5151-988X
  • Hernández-Laín, Aurelia
  • Sanchez-Calvin, Maria Teresa
  • Camacho, Ana
  • Rivas, Eloy
  • Campo-Barasoain, Andrea
  • Madruga, Marcos
  • Ortez, Carlos
  • Natera-de Benito, Daniel|||0000-0001-7764-2085
  • Nascimento, Andrés
  • Codina, Anna
  • Rodriguez, Maria Jose
  • Gallano, Pia|||0000-0001-8104-2197
  • González Quereda, Lidia|||0000-0003-0715-6414
Background Up to 7% of patients with Duchenne muscular dystrophy (DMD) or Becker muscular dystrophy (BMD) remain genetically undiagnosed after routine genetic testing. These patients are thought to carry deep intronic variants, structural variants or splicing alterations not detected through multiplex ligation-dependent probe amplification or exome sequencing. Methods RNA was extracted from seven muscle biopsy samples of patients with genetically undiagnosed DMD/BMD after routine genetic diagnosis. RT-PCR of the DMD gene was performed to detect the presence of alternative transcripts. Droplet digital PCR and whole-genome sequencing were also performed in some patients. Results We identified an alteration in the mRNA level in all the patients. We detected three pseudoexons in DMD caused by deep intronic variants, two of them not previously reported. We also identified a chromosomal rearrangement between Xp21.2 and 8p22. Furthermore, we detected three exon skipping events with unclear pathogenicity. Conclusion These findings indicate that mRNA analysis of the DMD gene is a valuable tool to reach a precise genetic diagnosis in patients with a clinical and anatomopathological suspicion of dystrophinopathy that remain genetically undiagnosed after routine genetic testing.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

An Integrated Transcriptomics and Genomics Approach Detects an X/Autosome Translocation in a Female with Duchenne Muscular Dystrophy

  • Segarra Casas, Alba|||0000-0001-5185-5031
  • Yépez, Vicente A.|||0000-0001-7916-3643
  • Demidov, German|||0000-0001-9075-4276
  • Laurie, Steven|||0000-0003-3913-5829
  • Esteve-Codina, Anna|||0000-0003-0361-2873
  • Gagneur, Julien|||0000-0002-8924-8365
  • Parkhurst, Yolande
  • Muni-Lofra, Robert|||0000-0002-8901-9140
  • Harris, Elizabeth
  • Marini-Bettolo, Chiara|||0000-0003-3795-6017
  • Straub, Volker|||0000-0001-9046-3540
  • Töpf, Ana
Duchenne and Becker muscular dystrophies, caused by pathogenic variants in DMD, are the most common inherited neuromuscular conditions in childhood. These diseases follow an X-linked recessive inheritance pattern, and mainly males are affected. The most prevalent pathogenic variants in the DMD gene are copy number variants (CNVs), and most patients achieve their genetic diagnosis through Multiplex Ligation-dependent Probe Amplification (MLPA) or exome sequencing. Here, we investigated a female patient presenting with muscular dystrophy who remained genetically undiagnosed after MLPA and exome sequencing. RNA sequencing (RNAseq) from the patient's muscle biopsy identified an 85% reduction in DMD expression compared to 116 muscle samples included in the cohort. A de novo balanced translocation between chromosome 17 and the X chromosome (t(X;17)(p21.1;q23.2)) disrupting the DMD and BCAS3 genes was identified through trio whole genome sequencing (WGS). The combined analysis of RNAseq and WGS played a crucial role in the detection and characterisation of the disease-causing variant in this patient, who had been undiagnosed for over two decades. This case illustrates the diagnostic odyssey of female DMD patients with complex structural variants that are not detected by current panel or exome sequencing analysis.